Synektik S.A.
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more
Synektik S.A. (SNT) - Total Assets
Latest total assets as of December 2025: zł605.37 Million PLN
Based on the latest financial reports, Synektik S.A. (SNT) holds total assets worth zł605.37 Million PLN as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Synektik S.A. - Total Assets Trend (2010–2025)
This chart illustrates how Synektik S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Synektik S.A. - Asset Composition Analysis
Current Asset Composition (December 2025)
Synektik S.A.'s total assets of zł605.37 Million consist of 68.7% current assets and 31.3% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 17.2% |
| Accounts Receivable | zł179.12 Million | 36.6% |
| Inventory | zł46.60 Million | 9.5% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł35.89 Million | 7.3% |
| Goodwill | zł3.65 Million | 0.8% |
Asset Composition Trend (2010–2025)
This chart illustrates how Synektik S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Synektik S.A.'s current assets represent 68.7% of total assets in 2025, an increase from 67.6% in 2010.
- Cash Position: Cash and equivalents constituted 17.2% of total assets in 2025, up from 3.7% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is accounts receivable at 36.6% of total assets.
Synektik S.A. Competitors by Total Assets
Key competitors of Synektik S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Synektik S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Synektik S.A. generates 1.39x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Synektik S.A. generates $ 21.04 in net profit.
Synektik S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.56 | 1.52 | 1.40 |
| Quick Ratio | 1.22 | 1.33 | 1.30 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł160.53 Million | zł 109.84 Million | zł 12.26 Million |
Synektik S.A. - Advanced Valuation Insights
This section examines the relationship between Synektik S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 9.38 |
| Latest Market Cap to Assets Ratio | 0.55 |
| Asset Growth Rate (YoY) | 30.3% |
| Total Assets | zł489.11 Million |
| Market Capitalization | $268.09 Million USD |
Valuation Analysis
Below Book Valuation: The market values Synektik S.A.'s assets below their book value (0.55 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Synektik S.A.'s assets grew by 30.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Synektik S.A. (2010–2025)
The table below shows the annual total assets of Synektik S.A. from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | zł489.11 Million | +30.34% |
| 2024-12-31 | zł375.26 Million | +25.12% |
| 2023-12-31 | zł299.92 Million | +26.82% |
| 2022-12-31 | zł236.48 Million | +48.09% |
| 2021-12-31 | zł159.69 Million | +12.76% |
| 2020-12-31 | zł141.61 Million | +13.20% |
| 2019-12-31 | zł125.10 Million | +15.20% |
| 2018-12-31 | zł108.59 Million | -5.77% |
| 2017-12-31 | zł115.23 Million | +26.97% |
| 2016-12-31 | zł90.75 Million | -13.08% |
| 2015-12-31 | zł104.40 Million | -2.24% |
| 2014-12-31 | zł106.79 Million | +1.60% |
| 2013-12-31 | zł105.11 Million | +70.74% |
| 2012-12-31 | zł61.56 Million | +21.99% |
| 2011-12-31 | zł50.47 Million | +304.05% |
| 2010-12-31 | zł12.49 Million | -- |